CoChat

Colorectal tumor-on-a-chip system: A 3D tool for precision onco-nanomedicine

Open access

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Abstract

This colorectal tumor-on-chip model is an original and reliable platform for high-throughput drug screening and genetic expression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/sciadv.aaw1317

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Design and characterization of the microfluidic chip. (A) Profilometer characterization: 3D map of the microfluidic chip. Representative image of quality control and characterization of the microfluidic chip features. The central chamber is 5 mm in diameter and 126 μm in depth, with a separate inlet and outlet for hydrogel injection. The two lateral channels, each 100 μm in width and 126 μm in depth, are not interconnected, opening up the possibility of perfusing two distinct solutions. (B) Schematic of chip design and zoom-in image of the concept of colorectal tumor-on-a-chip model: Round microfluidic central chamber in which HCT-116 cancer cells are embedded in Matrigel; HCoMECs are seeded in the side channels to form a 3D vessel-like assembly. (C) Establishment of a microvascular 3D microenvironment of colorectal tumor-on-a-chip: HCT-116 CRC cells embedded in Matrigel (in central chamber, stained in red) and HCoMECs (in lateral microchannels, stained in yellow) at day 1 (1D) and day 5 (5D) of culture. Endothelial cells start to invade the central chamber filled with Matrigel in response to VEGF presence. (D) Fluorescence microscopy image of microfluidic lateral channel mimicking prevascularization with HCoMECs after 5 days of culture [4′,6-diamidino-2-phenylindole (DAPI) blue, nuclei; phalloidin green, F-actin filaments]. Representative fluorescence microscopy close-up image of microchannel cross section showing endothelial cells aligning and creating an endothelialized lumen within the microchannel.
Fig. 1 Design and characterization of the microfluidic chip. (A) Profilometer characterization: 3D map of the microfluidic chip. Representative image of quality control and characterization of the microfluidic chip features. The central chamber is 5 mm in diameter and 126 μm in depth, with a separate inlet and outlet for hydrogel injection. The two lateral channels, each 100 μm in width and 126 μm in depth, are not interconnected, opening up the possibility of perfusing two distinct solutions. (B) Schematic of chip design and zoom-in image of the concept of colorectal tumor-on-a-chip model: Round microfluidic central chamber in which HCT-116 cancer cells are embedded in Matrigel; HCoMECs are seeded in the side channels to form a 3D vessel-like assembly. (C) Establishment of a microvascular 3D microenvironment of colorectal tumor-on-a-chip: HCT-116 CRC cells embedded in Matrigel (in central chamber, stained in red) and HCoMECs (in lateral microchannels, stained in yellow) at day 1 (1D) and day 5 (5D) of culture. Endothelial cells start to invade the central chamber filled with Matrigel in response to VEGF presence. (D) Fluorescence microscopy image of microfluidic lateral channel mimicking prevascularization with HCoMECs after 5 days of culture [4′,6-diamidino-2-phenylindole (DAPI) blue, nuclei; phalloidin green, F-actin filaments]. Representative fluorescence microscopy close-up image of microchannel cross section showing endothelial cells aligning and creating an endothelialized lumen within the microchannel.CC BY-NC · PubMed Central
Fig. 2 Endothelial cell invasion. (A) Schematic representation of HCoMECs in the lateral channels invading the central chamber in response to the presence of VEGF mixed in the Matrigel. (B) Formation of endothelial sprouts in the microfluidic device: Representative bright-field images of the chip taken at determined time points were analyzed with ImageJ. (C) Quantification of endothelial invasion. Data are presented as means ± SD (n = 9). The asterisk (*) denotes statistical differences (P < 0.01).
Fig. 2 Endothelial cell invasion. (A) Schematic representation of HCoMECs in the lateral channels invading the central chamber in response to the presence of VEGF mixed in the Matrigel. (B) Formation of endothelial sprouts in the microfluidic device: Representative bright-field images of the chip taken at determined time points were analyzed with ImageJ. (C) Quantification of endothelial invasion. Data are presented as means ± SD (n = 9). The asterisk (*) denotes statistical differences (P < 0.01).CC BY-NC · PubMed Central
Fig. 3 Schematic representation of fluorescent nanoparticle gradient formation. (A) Transmission electron microscopy image of individual CMCht/PAMAM dendrimer nanoparticle, representative image of chip connected to tubing perfusing the nanoparticle solution, and zoom-in confocal microscopy image confirming FITC-labeled CMCht/PAMAM dendrimer nanoparticles’ dispersion in Matrigel. (B) Panel of fluorescence microscopy images of FITC-labeled nanoparticle gradient up to 12 hours. (C) Quantification of fluorescence: Intensity [in arbitrary units (a.u.)] versus distance (in micrometers) across the chip up to 12 hours [measurements according to the direction of the green arrow indicated in (B)]. (D) 3D projection of FITC-labeled nanoparticle gradient according to fluorescence intensity.
Fig. 3 Schematic representation of fluorescent nanoparticle gradient formation. (A) Transmission electron microscopy image of individual CMCht/PAMAM dendrimer nanoparticle, representative image of chip connected to tubing perfusing the nanoparticle solution, and zoom-in confocal microscopy image confirming FITC-labeled CMCht/PAMAM dendrimer nanoparticles’ dispersion in Matrigel. (B) Panel of fluorescence microscopy images of FITC-labeled nanoparticle gradient up to 12 hours. (C) Quantification of fluorescence: Intensity [in arbitrary units (a.u.)] versus distance (in micrometers) across the chip up to 12 hours [measurements according to the direction of the green arrow indicated in (B)]. (D) 3D projection of FITC-labeled nanoparticle gradient according to fluorescence intensity.CC BY-NC · PubMed Central
Fig. 4 GEM drug effect on colorectal tumor model. (A) Release profile of GEM: Cumulative release (in hours) of GEM at pH 7.4 in phosphate-buffered saline (PBS), at 37°C and stirred at 60 rpm, determined by ultraviolet (UV) spectrophotometer set to 275 nm. The results are expressed as means ± SD (n = 6). (B) Schematic representation of experimental setup [perfusion of culture medium through one inlet and one outlet and of culture medium supplemented with GEM-loaded dendrimer nanoparticles (0.5 mg/ml) through the other inlet and outlet]; the areas defined for cell death quantification are delimited by dashed lines, and each ring is assigned D1 to D3 and M1 to M3. (C) Representative images of fluorescence microscopy images of live/dead assay performed on microfluidic chip at days 1 and 5. (D) Quantification of cell death, represented as percentage, based on the microscopy data. Data are presented as means ± SD (n = 3). The asterisk (*) denotes statistical differences (P < 0.05). Scale bars, 1000 μm. NP, nanoparticle; CTRL, control.
Fig. 4 GEM drug effect on colorectal tumor model. (A) Release profile of GEM: Cumulative release (in hours) of GEM at pH 7.4 in phosphate-buffered saline (PBS), at 37°C and stirred at 60 rpm, determined by ultraviolet (UV) spectrophotometer set to 275 nm. The results are expressed as means ± SD (n = 6). (B) Schematic representation of experimental setup [perfusion of culture medium through one inlet and one outlet and of culture medium supplemented with GEM-loaded dendrimer nanoparticles (0.5 mg/ml) through the other inlet and outlet]; the areas defined for cell death quantification are delimited by dashed lines, and each ring is assigned D1 to D3 and M1 to M3. (C) Representative images of fluorescence microscopy images of live/dead assay performed on microfluidic chip at days 1 and 5. (D) Quantification of cell death, represented as percentage, based on the microscopy data. Data are presented as means ± SD (n = 3). The asterisk (*) denotes statistical differences (P < 0.05). Scale bars, 1000 μm. NP, nanoparticle; CTRL, control.CC BY-NC · PubMed Central
Fig. 5 Gene expression analysis and immunocytochemistry on a chip. (A) Representation of hydrogel retrieval containing HCT-116 cells from the chip for gene expression analysis. (B) Gene expression of Ki-67, Casp-3, and MMP-1, in the absence (control) and presence of GEM, at days 1 and 5. The values for controls are represented by the dashed line. The asterisk (*) indicates significant differences when comparing the same condition at two different time points. The hash key (#) indicates significant differences when comparing to controls at the same time point. Data represent mean values of three independent experiments ± SD. RPS27A, ribosomal protein S27A. (C) Immunohistochemistry: In the center, a representative schematic of the entire chip that has reused an image from Fig. 4C (GEM NP gradient, top left) is depicted. The lateral images represent the zoom in at the cell level showing the immunocytochemistry Ki-67 staining after 5 days in culture [panels showing DAPI nuclei staining (blue), Ki-67 staining (green), F-actin staining (red), and merged image in colors].
Fig. 5 Gene expression analysis and immunocytochemistry on a chip. (A) Representation of hydrogel retrieval containing HCT-116 cells from the chip for gene expression analysis. (B) Gene expression of Ki-67, Casp-3, and MMP-1, in the absence (control) and presence of GEM, at days 1 and 5. The values for controls are represented by the dashed line. The asterisk (*) indicates significant differences when comparing the same condition at two different time points. The hash key (#) indicates significant differences when comparing to controls at the same time point. Data represent mean values of three independent experiments ± SD. RPS27A, ribosomal protein S27A. (C) Immunohistochemistry: In the center, a representative schematic of the entire chip that has reused an image from Fig. 4C (GEM NP gradient, top left) is depicted. The lateral images represent the zoom in at the cell level showing the immunocytochemistry Ki-67 staining after 5 days in culture [panels showing DAPI nuclei staining (blue), Ki-67 staining (green), F-actin staining (red), and merged image in colors].CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Cited by

Items 201–229 of 229

Metadata

Authors
Carvalho, M. R., Barata, D., Teixeira, L. M., Giselbrecht, S., Reis, R. L., Oliveira, J. M., Truckenmüller, R., & Habibovic, P.
Affiliations
  • 3B's Research Group (PT)
  • Maastricht University (NL)
  • Department of Instructive Biomaterials Engineering, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Netherlands.
Corresponding author
Oliveira, J. M.
Venue
Science Advances
Published
2019-05-03
Volume
5
Issue
5
Pages
eaaw1317-eaaw1317
ISSN
2375-2548 (ISSN-L)
OpenAlex
W2946416309
Cited by
230
References
49
Citations by year
2026: 18 · 2025: 26 · 2024: 44 · 2023: 40 · 2022: 32 · 2021: 38 · 2020: 29 · 2019: 3
FWCI
8.97
Type
journal article
Language
en
Open access
Locations
  • Science Advances (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, cc-by-nc)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
Funders
  • EMBO (Short-Term Fellowship 7232)
  • FCT (NORTE-01-0145-FEDER-000023, IF/01285/2015)
  • Norte Portugal Regional Operational Programme (NORTE-08-5369-FSE- 000044)
  • IET A F Harvey Engineering (IET A F Harvey Engineering Research Prize 2018 (ENG ThE CANCER))
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
Keywords
colorectal cancer, tumor-on-a-chip, 3D tumor models, precision nanomedicine, precision oncology, cancer nanomedicine
MeSH terms
Cell Survival, Humans, Colorectal Neoplasms, Gene Expression Regulation, Neoplastic, Coculture Techniques, Ki-67 Antigen, Matrix Metalloproteinase 1, Imaging, Three-Dimensional, Biomimetics, Microfluidics, HCT116 Cells, Cell Line, Tumor, Dendrimers, Nanomedicine, Caspase 3, Nanoparticles, Lab-On-A-Chip Devices, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.